ON DISTRIBUTION AND INHERITANCE OF ATYPICAL FORMS OF HUMAN SERUM CHOLINESTERASE, AS INDICATED BY DIBUCAINE NUMBERS

Author:

Kalow W.,Staron N.

Abstract

Type and activity of serum cholinesterase (pseudocholinesterase) have been studied in nearly 1700 human sera. The type was determined by an inhibition test with dibucaine; per cent inhibition achieved under specified conditions was termed dibucaine number (DN). The DNs can be classified into the three groups—usual, intermediate, and atypical. This triple division is consistent with the assumption that there exist two different types of enzyme which occur either in pure form or in a mixture; the proportion of the two enzymes in the mixture varies considerably from person to person but there are equal proportions on the average. Most observations on the inheritance of DN can be explained by the presence of two autosomal allelic genes without dominance, each gene causing the formation of one of the two types of enzyme. Some observations pointed to additional factors which may be variants of the normal gene, or modifying genes which influence the expressivity of the normal gene. There was an excess of male offspring in the investigated families but a connection with DN not established. In a healthy population, the frequency of the atypical gene was calculated to be 0.0140 ± 0.0036. Thus roughly one out of 30 persons has an intermediate DN but only one out of 3000 to 10,000 is expected to have an atypical DN.

Publisher

Canadian Science Publishing

Subject

General Medicine

Reference2 articles.

Cited by 147 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Contraindications for Local Anesthetics;Local Anesthesia in Dentistry;2024-01-12

2. Butyrylcholinesterase in lipid metabolism: A new outlook;Journal of Neurochemistry;2023-05-11

3. Pharmacogenomics testing: An overview;Pharmacogenomics;2023

4. Translational Research in Oncology;'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine;2020

5. Pharmacogenomics: Precision Medicine and Drug Response;Mayo Clinic Proceedings;2017-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3